Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
38.36 USD | +0.60% | -2.51% | +33.96% |
09/05 | Wedbush Raises Price Target on Revolution Medicines to $46 From $42, Maintains Outperform Rating | MT |
08/05 | Revolution Medicines Q1 Net Loss Narrows | MT |